Literature DB >> 24403300

Evaluation of the new brilliance GBS chromogenic medium for screening of Streptococcus agalactiae vaginal colonization in pregnant women.

Paul O Verhoeven1, Pauline Noyel, Julie Bonneau, Anne Carricajo, Nathalie Fonsale, Alain Ros, Bruno Pozzetto, Florence Grattard.   

Abstract

Three commercial chromogenic agar media were evaluated for Streptococcus agalactiae screening in 200 vaginal swabs from pregnant women. The sensitivity and specificity were 94.3% and 100% for Granada medium (bioMérieux), 100% and 90.3% for Brilliance GBS medium (Thermo Fisher Scientific), and 100% and 98.8% for ChromID STRB medium (bioMérieux), respectively.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24403300      PMCID： PMC3957761          DOI： 10.1128/JCM.02926-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  19 in total

1.  Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.

Authors:  Jennifer R Verani; Lesley McGee; Stephanie J Schrag
Journal:  MMWR Recomm Rep       Date:  2010-11-19

2.  Evaluation of polymerase chain reaction for group B streptococcus detection using an improved culture method.

Authors:  Kristin L Atkins; Robyn M Atkinson; Anthony Shanks; Curtis A Parvin; W Michael Dunne; Gilad Gross
Journal:  Obstet Gynecol       Date:  2006-09       Impact factor: 7.661

Review 3.  Prevalence of maternal group B streptococcal colonisation in European countries.

Authors:  Egle Barcaite; Arnoldas Bartusevicius; Rasa Tameliene; Mindaugas Kliucinskas; Laima Maleckiene; Ruta Nadisauskiene
Journal:  Acta Obstet Gynecol Scand       Date:  2008       Impact factor: 3.636

4.  Evaluation of a chromogenic agar for detection of group B streptococcus in pregnant women.

Authors:  Robin R Craven; Carol J Weber; Rebecca A Jennemann; W Michael Dunne
Journal:  J Clin Microbiol       Date:  2010-06-30       Impact factor: 5.948

5.  Evaluation of a new chromogenic medium (StrepB select) for detection of group B Streptococcus from vaginal-rectal specimens.

Authors:  L Louie; L Kotowich; H Meaney; M Vearncombe; A E Simor
Journal:  J Clin Microbiol       Date:  2010-10-20       Impact factor: 5.948

6.  Evaluation of the Xpert® group B streptococcus real-time polymerase chain reaction assay compared to StrepB Carrot Broth™ for the rapid intrapartum detection of group B streptococcus colonization.

Authors:  Deirdre Leigh Church; Heather Baxter; Tracie Lloyd; Beverley Miller; Daniel B Gregson
Journal:  Diagn Microbiol Infect Dis       Date:  2011-04       Impact factor: 2.803

7.  Multicenter study evaluating performance of the Smart Group B Streptococcus (GBS) assay using an enrichment protocol for detecting GBS colonization in patients in the antepartum period.

Authors:  Jeanne A Jordan; Geraldine Hall; Thomas Davis
Journal:  J Clin Microbiol       Date:  2010-07-28       Impact factor: 5.948

8.  Comparison of different sampling techniques and of different culture methods for detection of group B streptococcus carriage in pregnant women.

Authors:  Nabil A El Aila; Inge Tency; Geert Claeys; Bart Saerens; Piet Cools; Hans Verstraelen; Marleen Temmerman; Rita Verhelst; Mario Vaneechoutte
Journal:  BMC Infect Dis       Date:  2010-09-29       Impact factor: 3.090

9.  Comparison of BD GeneOhm real-time polymerase chain reaction with chromogenic and conventional culture methods for detection of group B Streptococcus in clinical samples.

Authors:  Dawn Smith; John D Perry; Larissa Laine; Angela Galloway; F Kate Gould
Journal:  Diagn Microbiol Infect Dis       Date:  2008-04-25       Impact factor: 2.803

10.  Diagnostic accuracy of a rapid real-time polymerase chain reaction assay for universal intrapartum group B streptococcus screening.

Authors:  Najoua El Helali; Jean-Claude Nguyen; Aïcha Ly; Yves Giovangrandi; Ludovic Trinquart
Journal:  Clin Infect Dis       Date:  2009-08-01       Impact factor: 9.079
View more
  6 in total

Review 1.  A Decade of Development of Chromogenic Culture Media for Clinical Microbiology in an Era of Molecular Diagnostics.

Authors:  John D Perry
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

2.  Clinical evaluation of the walk-away specimen processor and ESwab for recovery of Streptococcus agalactiae isolates in prenatal screening specimens.

Authors:  Blake W Buchan; Wendy J Olson; Tami-Lea A Mackey; Nathan A Ledeboer
Journal:  J Clin Microbiol       Date:  2014-03-12       Impact factor: 5.948

3.  Interplay of nasal and rectal carriage of Staphylococcus aureus in intensive care unit patients.

Authors:  Julie Gagnaire; Elisabeth Botelho-Nevers; Patricia Martin-Simoes; Jérôme Morel; Fabrice Zéni; Nicolas Maillard; Christophe Mariat; Cyrille H Haddar; Anne Carricajo; Nathalie Fonsale; Florence Grattard; Bruno Pozzetto; Frédéric Laurent; Philippe Berthelot; Paul O Verhoeven
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-07-04       Impact factor: 3.267

4.  Evaluation of the MRSA/SA ELITe MGB Assay for the Detection of Staphylococcus aureus in Bone and Joint Infections.

Authors:  R Labetoulle; J Rigaill; P O Verhoeven; A Carricajo; M Lleres-Vadeboin; F Grattard; B Pozzetto; C Cazorla; E Botelho-Nevers; B Boyer; C Dupieux-Chabert; F Laurent
Journal:  J Clin Microbiol       Date:  2021-11-17       Impact factor: 11.677

5.  Non-haemolytic and non-pigmented group b streptococcus, an infrequent cause of early onset neonatal sepsis.

Authors:  Javier Rodriguez-Granger; Barbara Spellerberg; Daniela Asam; Manuel Rosa-Fraile
Journal:  Pathog Dis       Date:  2015-10-07       Impact factor: 3.166

6.  Performance of Hitchens-Pike-Todd-Hewitt medium for group B streptococcus screening in pregnant women.

Authors:  Simone Cristina Castanho Sabaini de Melo; Angela Andréia França Gavena; Flávia Teixeira Ribeiro Silva; Ricardo Castanho Moreira; Regiane Bertin de Lima Scodro; Rosilene Fressatti Cardoso; Vera Lúcia Dias Siqueira; Rúbia Andreia Faleiros de Pádua; Maria Dalva de Barros Carvalho; Sandra Marisa Pelloso
Journal:  PLoS One       Date:  2015-04-16       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.